Accès gratuit
Numéro
Med Sci (Paris)
Volume 29, Numéro 5, Mai 2013
Page(s) 463 - 468
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2013295007
Publié en ligne 28 mai 2013
  1. Patti GJ, Yanes O, Siuzdak G. Innovation: metabolomics: the apogee of the omics trilogy. Nat Rev Mol Cell Biol 2012 ; 13 : 263–269. [CrossRef] [PubMed]
  2. Ricquier D. Maladies héréditaires du métabolisme et apports de la métabolomique. Med Sci (Paris) 2005 ; 21 : 512–516. [CrossRef] [EDP Sciences] [PubMed]
  3. Smolinska A, Blanchet L, Buydens LM, Wijmenga SS. NMR and pattern recognition methods in metabolomics: from data acquisition to biomarker discovery: a review. Anal Chim Acta 2012 ; 750 : 82–97. [CrossRef] [PubMed]
  4. Zhang A, Sun H, Wang P, et al. Recent and potential developments of biofluid analyses in metabolomics. J Proteomics 2012 ; 75 : 1079–1088. [CrossRef] [PubMed]
  5. Ganti S, Taylor SL, Abu Aboud O, et al. Kidney tumor biomarkers revealed by simultaneous multiple matrix metabolomics analysis. Cancer Res 2012 ; 72 : 3471–3479. [CrossRef] [PubMed]
  6. Weiss RH, Kim K. Metabolomics in the study of kidney diseases. Nat Rev Nephrol 2011 ; 8 : 22–33. [CrossRef] [PubMed]
  7. Ganti S, Weiss RH. Urine metabolomics for kidney cancer detection and biomarker discovery. Urol Oncol 2011 ; 29 : 551–557. [CrossRef] [PubMed]
  8. Mitrevski BS, Kouremenos KA, Marriott PJ. Accelerating analysis for metabolomics, drugs and their metabolites in biological samples using multidimensional gas chromatography. Bioanalysis 2009 ; 1 : 367–391. [CrossRef] [PubMed]
  9. Vuckovic D. Current trends and challenges in sample preparation for global metabolomics using liquid chromatography-mass spectrometry. Anal Bioanal Chem 2012 ; 403 : 1523–1548. [CrossRef] [PubMed]
  10. Lei Z, Huhman DV, Sumner LW. Mass spectrometry strategies in metabolomics. J Biol Chem 2011 ; 286 : 25435–25442. [CrossRef] [PubMed]
  11. Barding GA, Jr, Salditos R, Larive CK. Quantitative NMR for bioanalysis and metabolomics. Anal Bioanal Chem 2012 ; 404 : 1165–1179. [CrossRef] [PubMed]
  12. Casado-Vela J, Cebrian A, Gomez del Pulgar MT, Lacal JC. Approaches for the study of cancer: towards the integration of genomics, proteomics and metabolomics. Clin Transl Oncol 2011 ; 13 : 617–628. [CrossRef] [PubMed]
  13. D’Alessandro A, Zolla L. Metabolomics and cancer drug discovery: let the cells do the talking. Drug Discov Today 2011 ; 17 : 3–9. [CrossRef] [PubMed]
  14. Issaq HJ, Fox SD, Chan KC, Veenstra TD. Global proteomics and metabolomics in cancer biomarker discovery. J Sep Sci 2011 ; 34 : 3484–3492. [CrossRef] [PubMed]
  15. Metallo CM. Expanding the reach of cancer metabolomics. Cancer Prev Res (Phila) 2012 ; 5 : 1337–1340. [CrossRef] [PubMed]
  16. Claudino WM, Goncalves PH, di Leo A, et al. Metabolomics in cancer: a bench-to-bedside intersection. Crit Rev Oncol Hematol 2012 ; 84 : 1–7. [CrossRef] [PubMed]
  17. Ikeda A, Nishiumi S, Shinohara M, et al. Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer. Biomed Chromatogr 2012 ; 26 : 548–558. [CrossRef] [PubMed]
  18. Nishiumi S, Kobayashi T, Ikeda A, et al. A novel serum metabolomics-based diagnostic approach for colorectal cancer. PLoS One 2012 ; 7 : e40459. [CrossRef] [PubMed]
  19. Bertini I, Cacciatore S, Jensen BV, et al. Metabolomic NMR fingerprinting to identify and predict survival of patients with metastatic colorectal cancer. Cancer Res 2012 ; 72 : 356–364. [CrossRef] [PubMed]
  20. Cao M, Zhao L, Chen H, et al. NMR-based metabolomic analysis of human bladder cancer. Anal Sci 2012 ; 28 : 451–456. [CrossRef] [PubMed]
  21. Wei S, Liu L, Zhang J, et al. Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer. Mol Oncol 2012 pii: S1574–7891(12)00101–9
  22. Budczies J, Denkert C, Muller BM, et al. Remodeling of central metabolism in invasive breast cancer compared to normal breast tissue -a GC-TOFMS based metabolomics study. BMC Genomics 2012 ; 13 : 334. [CrossRef] [PubMed]
  23. Eckhart AD, Beebe K, Milburn M. Metabolomics as a key integrator for «omic» advancement of personalized medicine and future therapies. Clin Transl Sci 2012 ; 5 : 285–288. [CrossRef] [PubMed]
  24. Wishart DS, Jewison T, Guo AC, et al. HMDB 3.0-The human metabolome database in 2013. Nucleic Acids Res 2013 ; 41 : D801–D807. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.